Journal of Cancer Clinical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Short Communication - Journal of Cancer Clinical Research (2023) Volume 6, Issue 2

A cross-sectional study of penile cancer

Deenick David*

Department of chemotherapy, university of dakin, Australia

*Corresponding Author:
Deenick David
Department of chemotherapy
university of dakin

Received:27-May-2023, Manuscript No. AACCR-23-102868 ; Editor assigned:30-May-2023, PreQC No. AACCR-23-102868(PQ); Reviewed:14-Jun-2023, QC No. AACCR-23-102868 ; Revised:19-Jun-2023, Manuscript No. AACCR-23-102868(R); Published:26-Jun-2023, DOI:10.35841/ aaccr-6.1.144

Citation: David D. A cross-Sectional Study of Penile Cancer. J Can Clinical Res. 2023; 6(2):144

Visit for more related articles at Journal of Cancer Clinical Research




Human papillomavirus (HPV) has been perceived as a significant gamble calculate penile disease. This study meant to examine the HPV subtypes and combination status in Chinese patients. Tests were gathered from 103 penile malignant growth patients matured 24-90 years somewhere in the range of 2013 and 2019. We found that HPV disease rate was 72.8%, with 28.0% joining. The maturing patients were more defenseless to HPV (p = 0.009). HPV16 was the most incessant subtype noticed (52/75) and displayed the most elevated recurrence of mix occasions, with 11 out of 30 single contamination cases showing joining positive. The HPV mixes locales in the viral genome were not arbitrarily appropriated, the breakpoints were improved in the E1 quality (p = 0.006) however somewhat scant in L1, E6 and E7. Our exploration could give a few insights how HPV prompts the movement of penile malignant growth[1].

Penile disease is a sort of uncommon malignant growth in big time salary nations, and the commonness of penile malignant growth is 0.1-1 for every 100,000 individuals. In any case, the worldwide frequency changes clearly between various populaces. In some African, Asian, and South American districts, penile disease can comprise up to 10% of male malignancies. Analysis included affirmation of the histologic subtypes, histopathologic reviewing and the sufficiency of the example for HPV testing. For growth tissue tests, just those areas with the affirmed presence (>70%) of cancer cells were chosen for additional HPV DNA examination. At long last, 125 cases were predictable with the recording of obsessive data, and 14 examples were rejected because of the changeability of pathology[2].

The HPV DNA commonness was determined among HPV test hybridization catch sequencing cases. We examined the relationship between the HPV pervasiveness, age at determination, growth grade, and histopathological subtypes. Contrasts in all out factors were surveyed utilizing Pearson's Chi square test or Fisher's precise test and constant factors were evaluated utilizing t-test or examination of change. Information examinations were performed with R studio Measurable importance was set at two-sided 0.05. To investigate the relationship between HPV species and coordination rate, we led a similar examination of the extent of viral combination by HPV genotype. To decrease possible bewildering impacts from co-disease with HPV, just cases with single genotype disease were investigated. In our examination of different HPV genotypes, HPV16 displayed the most noteworthy recurrence of coordination occasions, with 11 out of 30 cases showing combination positive. Conversely, no reconciliation occasions were identified in instances of HPV39, HPV73, or HPV18. The advantage of perioperative oncological therapy in men with penile disease is questionable. In 2015, treatment suggestions were unified in Sweden and treatment rules were refreshed. To assess assuming that the utilization of oncological therapy in men with penile disease expanded after the presentation of unified suggestions, and whether such treatment is related with better endurance[3].

We previously surveyed the adjustment of the extent of patients with a sign for perioperative oncological treatment who really got such treatment. Second, we utilized Cox relapse to ascertain changed peril proportions (HRs) and 95% certainty stretches (CIs) for illness explicit mortality related with perioperative treatment. Correlations were made for both all men without perioperative treatment and for the individuals who didn't get treatment yet who needed evident contraindications for treatment[4].

The utilization of perioperative oncological treatment expanded from 2000 to 2018, from 32% of patients with a sign for treatment during the initial 4 yr to 63% during the last 4 yr. In contrast with patients possibly qualified for oncological treatment who didn't get it, the people who were dealt with had a 37% lower hazard of illness explicit passing (HR 0.63, 95% CI 0.40-0.98). Stage relocation in view of enhancements in analytic apparatuses over the long haul might have swelled the later endurance gauges. An impact of remaining frustrating because of comorbidity and other potential confounders can't be prohibited. The utilization of perioperative oncological therapy expanded after the centralisation of penile malignant growth care in Sweden. Albeit the observational review configuration blocks causal derivation, the discoveries propose that perioperative therapy in patients with penile disease qualified for treatment might be related with better endurance[5].


  1. Akogbe GO, Ajidahun A, Sirak B, et al. Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States.Int J Cancer. 2012;131(3):E282-91.
  2. Indexed at, Google ScholarCross Ref

  3. Alemany L, Cubilla A, Halec G, et al. Role of human papillomavirus in penile carcinomas worldwide.Eur Urol. 2016;69(5):953-61.
  4. Indexed at, Google Scholar, Cross Ref

  5. Chu C, Chen K, Tan X, et al.Prevalence of human papillomavirus and implication on survival in Chinese penile cancer.InSeminars in Ultrasound, CT and MRI. 2005;26(4):259-268.
  6. Indexed at, Google Scholar, Cross Ref

  7. Maibom SL, Jakobsen JK, Aagaard M, et al. DaPeCa-4: outcome in penile cancer patients with N3 disease due to extra nodal extension treated with surgery and chemo-irradiation.Scand J Urol. 2020;54(4):334-8.
  8. Indexed at, Google Scholar, Cross Ref

  9. Khurud P, Krishnatry R, Telkhade T, et al. Impact of adjuvant treatment in pN3 penile cancer.Clin Oncol. 2022;34(3):172-8.
  10. Indexed at, Google Scholar, Cross Ref

Get the App